Cargando…
Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury
Background: Anti-tuberculosis drug-induced liver injury (ATB-DILI) is an adverse reaction with a high incidence and the greatest impact on tuberculosis treatment. However, there is a lack of effective biomarkers for the early prediction of ATB-DILI. Herein, this study uses UPLC‒MS/MS to reveal the p...
Autores principales: | Wang, Ming-Gui, Wu, Shou-Quan, Zhang, Meng-Meng, He, Jian-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641415/ https://www.ncbi.nlm.nih.gov/pubmed/36386176 http://dx.doi.org/10.3389/fphar.2022.1044808 |
Ejemplares similares
-
Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study
por: Wang, Ming-Gui, et al.
Publicado: (2022) -
Comprehensive metabolomics and lipidomics profiling uncovering neuroprotective effects of Ginkgo biloba L. leaf extract on Alzheimer’s disease
por: Liu, Li-Wei, et al.
Publicado: (2022) -
Plasma metabolomic and lipidomic alterations associated with COVID-19
por: Wu, Di, et al.
Publicado: (2020) -
An Investigation of the Risk Factors Associated With Anti-Tuberculosis Drug-Induced Liver Injury or Abnormal Liver Functioning in 757 Patients With Pulmonary Tuberculosis
por: Zhong, Tao, et al.
Publicado: (2021) -
Metabolomic and lipidomic studies on the intervention of taurochenodeoxycholic acid in mice with hyperlipidemia
por: Cui, Na, et al.
Publicado: (2023)